Efficacy and Safety of Intravenous Chimeric Antigen Receptor T-Cell Therapy in Adults with Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Srisurapanont, Karan [1 ]
Nangsue, Chatchaya [1 ]
Tantiworawit, Adisak [2 ]
机构：
[1] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Hematol, Chiang Mai, Thailand
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
627
引用
收藏
页码：9557 / 9558
页数：2
相关论文
共 50 条
  • [1] Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data
    Zhou, Jing
    Wang, Zhenhao
    Wang, Hanyu
    Cao, Yang
    Wang, Gaoxiang
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [2] Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
    Asghar, Noureen
    Masood, Adeel
    Dhaliwal, Armaan
    Khurana, Sharad
    Davis, James
    Hashmi, Hamza
    Husnain, Muhammad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : 15 - 21
  • [3] Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis
    Jang, Jong Keon
    Pyo, Junhee
    Suh, Chong Hyun
    Park, Hye Sun
    Chae, Young Kwang
    Kim, Kyung Won
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy in Children With Central Nervous System Leukemia
    Zhang, Lin
    Zuo, Yingxi
    Lu, Aidong
    Wu, Jun
    Jia, Yueping
    Wang, Yu
    Zhang, Leping
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E410 - E414
  • [5] Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysis
    Elgohary, Ghada
    Yang, Yang
    Gergis, Mia
    Yi, Dongni
    Gergis, Usama
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e142 - e151
  • [6] Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
    Ryan, Christine E.
    Zon, Rebecca L.
    Redd, Robert
    Fisher, David C.
    Shouval, Roni
    Kumar, Anita
    Crombie, Jennifer L.
    Sadrzadeh, Hossein
    Kim, Austin I.
    Nayak, Lakshmi
    Chukwueke, Ugonma N.
    Jacobson, Caron A.
    Frigault, Matthew J.
    Palomba, M. Lia
    Armand, Philippe
    Epstein-Peterson, Zachary
    Merryman, Reid W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 774 - 780
  • [7] Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis
    Alsouqi, Aseel
    Ahmed, Gulrayz
    Wang, Juntian
    Cassanello, Guilio
    Szabo, Aniko
    Rojek, Alexandra E.
    Riedell, Peter A.
    Awan, Farrukh
    Samples, Laura
    Shadman, Mazyar
    Hu, Marie
    Bachanova, Veronika
    Wesson, William
    Ahmed, Nausheen
    Iqbal, Madiha
    Kharfan-Dabaja, Mohamed A.
    Scordo, Michael
    Johnson, P. Connor
    Chen, Yi-Bin
    Ito, Sawa
    Hamadani, Mehdi
    Frigault, Matthew
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1624 - 1627
  • [8] Chimeric antigen receptor T-cell therapy in relapsed or refractory mantle cell lymphoma: a systematic review and meta-analysis
    Wan, Haixiang
    Weng, Songqin
    Sheng, Sumei
    Kuang, Zilin
    Wang, Qingming
    Hu, Linhui
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Chimeric Antigen Receptor T-cell (CAR T) Therapy for Hematologic and Solid Malignancies: Efficacy and Safety-A Systematic Review with Meta-Analysis
    Yu, Wen-Liang
    Hua, Zi-Chun
    CANCERS, 2019, 11 (01):
  • [10] The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis
    Liu, Jile
    An, Yuxin
    Sun, Rui
    Zhang, Xiaomei
    Guo, Shujing
    Gao, Xuejin
    Zhao, Mingfeng
    FRONTIERS IN ONCOLOGY, 2025, 14
12345